Koronis Pharmaceuticals, Inc. to Present at 2010 Biotechnology Industry Organization (BIO) International Convention
4/29/2010 10:55:54 AM
SEATTLE--(BUSINESS WIRE)--Koronis Pharmaceuticals, Inc., a biotechnology company focused on the development of antiviral therapeutics, today announced that it will present at the 2010 BIO International Convention, being held May 3-6 at McCormick Place, Chicago, IL. Jean-Pierre Laurent, Ph.D., Koronis COO, will present clinical data demonstrating proof-of-concept of Koronis’ lead HIV therapeutic, KP-1461. Dr. Laurent’s presentation will occur as part of the BIO Business Forum on Wednesday, May 5, at 10:45 a.m. CT, Room C.